Latest Administration News

Benz Mining Corp reported a CAD 3.58 million net loss for Q1 2025, driven by ramped-up exploration at its newly acquired Western Australian gold projects. The company bolstered its cash position with a CAD 27 million private placement post-period, aiming to fuel further resource growth.

My Rewards International Limited has announced a pro-rata entitlement offer aiming to raise up to $4.1 million, a key step toward meeting ASX reinstatement conditions after a prolonged trading suspension. The offer includes a debt conversion proposal and is partially underwritten by major shareholders.

My Rewards International Limited (ASX – MRI) has announced a pro rata non-renounceable entitlement offer aiming to raise up to $4.12 million, primarily to reduce debt and strengthen working capital. The offer is partially underwritten and open to shareholders in select countries, with key dates set for September and October 2025.

Camplify Holdings has responded to ASX concerns over a delayed director interest notice, revealing internal process failures and promising tighter compliance measures.

Centrex Limited and its subsidiary Agriflex have completed their deed of company arrangement, ending external administration and transferring ownership to PRL Global Limited.

Scout Security has completed the first tranche of a $600,000 capital raise amid its ASX trading suspension, aiming to settle debts and progress towards relisting.

Ansell Limited has updated its FY25 final dividend announcement, confirming the dividend amount, exchange rate, and Dividend Reinvestment Plan pricing, providing clarity for shareholders ahead of payment.

Regal Partners Limited has announced a fully franked ordinary dividend of AUD 0.06 per share for the six months ending June 2025, alongside confirmation of its dividend reinvestment plan price at AUD 2.70.

Altair Minerals has secured a world-class exploration team led by Pascal Van Osta to advance its Greater Oko gold project in Guyana, with fieldwork set to begin imminently targeting a 10km strike of highly prospective shear zone.

US Masters Residential Property Fund reported robust first-half sales and significant debt reduction, while navigating a modest portfolio valuation dip primarily in New York.

The US Centers for Medicare & Medicaid Services has recommended a final reimbursement price of US$1,328 for Pacific Edge’s advanced bladder cancer diagnostic test, Cxbladder Triage Plus, marking a significant increase from earlier proposals.

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.